ACRV

1.15017.86%
CM

Charles M. Baum

Independent Director & Chair of Clinical Advisory Board

Dr. Charles M. Baum, also known as Chuck, is Executive Chairman of Terremoto Biosciences, Inc. from August 2026. Dr. Baum was CEO of Terremoto Biosciences, Inc. until August 2026. Dr. Baum is Independent Director of Acrivon Therapeutics, Inc. since June 2023. Dr. Baum is Independent Director & Chair of Clinical Advisory Board of PMV Pharmaceuticals, Inc. from 2024. Dr. Baum is CFO & Director of Terremoto Biosciences, Inc. Dr. Baum was Member of the Scientific Advisory Board of ALX Oncology Holdings Inc. from October 2020 to 2026. Dr. Baum was CEO & Director of Terremoto Biosciences, Inc. Dr. Baum was Chief Executive Officer of Terremoto Biosciences, Inc. from July 2024. Dr. Baum has Pst Dc Trn from Stanford University. Dr. Baum has M.D. from Washington University School of Medicine. Dr. Baum has Ph.D. in Immunology from Washington University School of Medicine.

Positions